Research > Neurosciences

Neuroimmunology

Number of publications
122
Publications search

  • Fernandez, Oscar; Fernandez, Victoria; Baumstarck-Barrau, Karine; Munoz, Luis; Gonzalez Alvarez, Maria del Mar; Carlos Arrabal, Jose; Leon, Antonio; Alonso, Ana; Carlos Lopez-Madrona, Jose; Bustamante, Rafael; Luque, Gloria; Guerrero, Miguel; di Cantogno, Elisabetta Verdun; Auquier, Pascal; MusiQoL Study Grp Spain

    Validation of the spanish version of the Multiple Sclerosis International Quality of Life (Musiqol) questionnaire.

    BMC NEUROLOGY 11 127-127. .

    [doi:10.1186/1471-2377-11-127]

  • Arroyo, E.; Grau, C.; Ramo-Tello, C.; Parra, J.; Sanchez-Solino, O.; GAP Study Grp

    Adherence to disease-modifying therapies in spanish patients with relapsing multiple sclerosis: two-year interim results of the global adherence project.

    EUROPEAN NEUROLOGY 65 59-67. .

    [doi:10.1159/000323216]

  • Purroy, F.; Begue, R.; Gil, M. I.; Quilez, A.; Sanahuja, J.; Brieva, L.; Pinol-Ripoll, G.

    Patterns of diffusion-weighted magnetic resonance imaging associated with etiology improve the accuracy of prognosis after transient ischaemic attack.

    EUROPEAN JOURNAL OF NEUROLOGY 18 121-128. .

    [doi:10.1111/j.1468-1331.2010.03080.x]

  • Devonshire, V.; Lapierre, Y.; Macdonell, R.; Ramo-Tello, C.; Patti, F.; Fontoura, P.; Suchet, L.; Hyde, R.; Balla, I.; Frohman, E. M.; Kieseier, B. C.; GAP Study Grp

    The Global Adherence Project (GAP): a multicenter observational study on adherence to disease-modifying therapies in patients with relapsing-remitting multiple sclerosis

    EUROPEAN JOURNAL OF NEUROLOGY 18 69-77. .

    [doi:10.1111/j.1468-1331.2010.03110.x]

  • Purroy F; Quílez-Martínez A; Pardina M; Suárez-Luis I; Sanahuja-Montesinos J; Brieva L; Piñol-Ripoll G

    Qué puede aportar la determinación del grosor íntima-media carotídeo al proceso diagnóstico del ataque isquémico transitorio?

    REVISTA DE NEUROLOGIA 51 721-728. .

  • Purroy, Francisco; Pinol-Ripoll, Gerard; Quilez, Alejandro; Sanahuja, Jordi; Brieva, Luis; Suarez Luis, Idalmis

    Validación de las escalas ABCDI y ABCD2I en el registro de pacientes con ataque isquémico transitorio de Lleida (REGITELL).

    MEDICINA CLINICA 135 351-356. .

    [doi:10.1016/j.medcli.2009.10.054]

  • Bosma, L. V. A. E.; Kragt, J. J.; Brieva, L.; Khaleeli, Z.; Montalban, X.; Polman, C. H.; Thompson, A. J.; Tintore, M.; Uitdehaag, B. M. J.

    Progression on the Multiple Sclerosis Functional Composite in multiple sclerosis: what is the optimal cut-off for the three components?

    MULTIPLE SCLEROSIS JOURNAL 16 862-867. .

    [doi:10.1177/1352458510370464]

  • Otero, S.; Batlle, J.; Bonaventura, I.; Brieva, Ll; Bufill, E.; Cano, A.; Carmona, O.; Escartin, A.; Marco, M.; Moral, E.; Munteis, E.; Nos, C.; Pericot, I.; Perkal, H.; Ramio-Torrenta, Ll; Ramo-Tello, C.; Saiz, A.; Sastre-Garriga, J.; Tintore, M.; Vaque, J.; Montalban, X.

    Multiple sclerosis epidemiological situation update: pertinence and set-up of a population based registry of new cases in Catalonia

    REVISTA DE NEUROLOGIA 50 623-633. .

  • Purroy, F.; Coll, B.; Oro, M.; Seto, E.; Pinol-Ripoll, G.; Plana, A.; Quilez, A.; Sanahuja, J.; Brieva, L.; Vega, L.; Fernandez, E.

    Predictive value of ankle brachial index in patients with acute ischaemic stroke.

    EUROPEAN JOURNAL OF NEUROLOGY 17 602-606. .

    [doi:10.1111/j.1468-1331.2009.02874.x]

  • Purroy, F.; Sole, A.; Oro, M.; Quilez-Martinez, A.; Llobet, C.; Sanahuja-Montesinos, J.; Brieva, L.; Cabre-Olle, X.; Seto, E.; Pinol-Ripoll, G.

    Study of the prognostic implications in patients with a transient ischaemic attack before the implementation of an agreed process of treatment in the health region of Lleida

    REVISTA DE NEUROLOGIA 50 77-83. .

  • Purroy F; Solé A; Oró M; Quilez-Martínez A; Llobet C; Sanahuja-Montesinos J; Brieva L; Cabré-Ollé X; SETO GORT, ELOISA; Piñol-Ripoll G

    Estudio de las implicaciones pronósticas del paciente con ataque isquémico transitorio antes de la implantación de un proceso consensuado de tratamiento en la región sanitaria de Lleida.

    REVISTA DE NEUROLOGIA 50 77-83. .

  • Montalban, X.; Sastre-Garriga, J.; Tintore, M.; Brieva, L.; Aymerich, F. X.; Rio, J.; Porcel, J.; Borras, C.; Nos, C.; Rovira, A.

    A single-center, randomized, double-blind, placebo-controlled study of interferon beta-1b on primary progressive and transitional multiple sclerosis.

    MULTIPLE SCLEROSIS JOURNAL 15 1195-1205. .

    [doi:10.1177/1352458509106937]